Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples